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Letters to the EditorReply to the Editor:
We appreciate the comments of Drs Bonde
and Graham regarding the surgical man-
agement of massive pulmonary embolism.
To improve visualization of the pulmonary
artery tree, they used cardiopulmonary by-
pass with aortic clamping and cardioplegia.
They reported their experience in 3 pa-
tients.
We believe aortic clamping and cardio-
plegia are not necessary, because reduc-
tions in flows have been brief in duration
and this has provided adequate visualiza-
tion in the majority of cases. One problem
with their approach will be right ventricular
dysfunction. Most patients have some de-
gree of postoperative right ventricular dys-
function, and aortic clamping will certainly
make this worse. In our series, several pa-
tients demonstrated postoperative right ven-
tricular dysfunction necessitating inotropic
support despite our practice of avoiding aor-
tic clamping.
In summary, we believe the risks of
right ventricular dysfunction imposed by aor-
tic clamping and cardioplegia are greater than
the benefits of improved visualization in the
occasional case.
John G. Byrne, MD
Marzia Leacche, MD
Department of Cardiac Surgery
Vanderbilt University Medical Center
Nashville, TN 37232-8802
doi:10.1016/j.jtcvs.2005.08.071
Assumed oxygen consumption in the
determination of cardiac output:
Assume carefully . . .
To the Editor:
With great interest we read the article of
Fakler and coworkers1 in which they warn
of large errors in determination of cardiac
output when using the Fick principle with
assumed oxygen consumption (VO2).1 We
share the concerns of the authors, especially
in specific patients with potentially deviating
VO2 compared with a control group, such
as children with congenital heart disease.2,3
However, methodological errors in the study
of Fakler and associates may surpass the er-
ror introduced by the use of assumed VO2 in
these patients.
Although we hope that our major con-
cern is based on typographical errors, we
fear a major flaw in the analysis in this
study. According to the described equa-
tion in the Methods section, the assumed
VO2 values derived from the LaFarge
504 The Journal of Thoracic and Cardiovaand Miettinen equations are being divided
by body surface area (BSA) to reach in-
dexed values. However, LaFarge and Mi-
ettinen4 derived their equation for indexed
VO2! In other words, the presented equa-
tions are incorrect and will lead to highly
erroneous values, resulting in false high
values in smaller patients (BSA 1 m2) and
false low values in larger patients (BSA  1
m2). In their original study, Lafarge and
Miettinen4 included over 800 patients and
found indexed VO2 values between 112
and 162 mL · min1 · m2. From Figure 4
in the current article, it can be estimated
that in this study more than 70% of the
VO2LaFarge/Miettinen values are outside this
range, whereas the authors claim that the
studied patients were in the same age range
as the original LaFarge and Miettinen pop-
ulation. This strongly suggests that the au-
thors indeed applied a wrong equation to
assume indexed VO2. In this population
with a mean age of 11.3 years, this could be
one explanation for the large overestima-
tion of assumed VO2.
By analyzing indexed values of VO2 in-
stead of the measured quantity, the authors
make it impossible to analyze whether the
occurring errors correlate with the absolute
magnitude of VO2. In general, this should be
done when comparing measurement methods
for accuracy.3
Second, it can be questioned whether
absolute values of VO2 determined with
the Deltatrac II system (Datex, Engström,
Helsinki, Finland) are acceptable as a gold
standard. Although this system has been
validated in vivo, this was mainly for its
use in metabolic studies, requiring accurate
and stable respiratory quotients. It has not
been well validated for absolute values of
VO2 in mechanically ventilated children, in
whom the prevention of air leakage is ex-
tremely cumbersome but imperative for ac-
curate measurement of absolute values.
Finally, in contrast to the statement of the
authors, in patients with congenital heart de-
fects, adequate values for VO2 are not nec-
essary for the determination of shunt ratio.
In conclusion, we absolutely agree with
the authors that routine use of assumed
VO2 may result in errors in the determina-
tion of Fick cardiac output. Unfortunately,
we question whether the presented data can
be used to support this common opinion.
R. M. F. Berger, MD, PhD
A. Bergstra, BScBeatrix Children’s Hospital
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Division of Pediatric Cardiology
Thorax Center
University Medical Center Groningen
University of Groningen
Groningen, The Netherlands
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Reply to the Editor:
With great interest we read the comments
of Berger and Bergstra, and we appreciate
their remarks concerning our article.1 We
have to confirm with regret that there is a
typographical error in the published ver-
sion of our article. The correct version of
the LaFarge/ Miettinen formula2 is as fol-
lows:
For females: VO2/BSA (138.1 – 17.04
ln(age)  0.378  HR) (mL/min)/m2
For males: VO2/BSA ( 138.1 – 11.49
ln(age)  0.378  HR) (mL/min)/m2
However, we used this correct version
for the analysis of our data, so the data and
figures we presented are correct.
The difference between the populations
and the regimen of general anesthesia and
relaxation might explain the different find-
ings of assumed oxygen consumption (VO2)
values.
Secondly, Berger and Bergstra ques-
tioned whether the determination of VO2
with the Deltatrac II system (Datex, Eng-
ström, Helsinki, Finland) is acceptable as a
reference method.
Behrends and colleagues3 showed an
acceptably accurate determination of VO2
using the Deltatrac II system compared
with mass spectrometry and wet gas spi-
rometry in an in vitro model for ventilated
neonates: mean bias 3.8 % (SD 5.7%).
Letters to the EditorWeyland and colleagues4 described a
laboratory validation in a pediatric setting
comparing the Deltatrac system with mass
spectrometry and wet gas spirometry. They
found a mean bias of 3.2 % (SD 11.5 %),
including the following conditions: FIO2
(inspired oxygen fraction) 0.21 to 0.8, FIO2-
FEO2 (expired oxygen fraction) 0.01 to
0.05, VE (expired volume) 300 to 6000
mL/min, VT (tidal volume) 8 to 300 mL,
Paw (airway opening pressure) 10 to 60
mbar, and relative humidity 10% to 60%.4
These wide ranges of respiratory variables
might explain the wider ranges of the stan-
dard deviation.
Bauer and colleagues5 performed an in
vitro validation and clinical testing for venti-
lated preterm infants. In vitro validation was
done by methanol burning during intermit-
tent positive-pressure ventilation (IPPV) with
two commonly used ventilators: Sechrist
IV 100B (Sechrist Industries, Anaheim,
Calif) and the Infant star software version
83 (Nellcor Puritan Bennet Inc, Carlsbad,
Calif). They found a mean difference be-
tween VO2 measurements using the Delta-
trac II system and VO2 determined by the
methanol burning method from 2% to 2 %
(max SD  5%) depending on the ventilator
and peak inspiratory pressure they used.
For clinical testing, they developed a
breath collector to avoid gas leakage around
uncuffed endotracheal tubes or during na-
sal continuous positive airway pressure
(CPAC). This test arrangement simulta-
neously sampled expired air expelled at the
ventilator and escaping via the tube leak
from the infant=s mouth and nose and al-
lowed VO2 measurements that are not af-
fected by tube leaks.
They studied 15 preterm infants during
IPPV and 10 preterm infants during nasal
CPAP and determined a mean difference of
VO2 of 6.5 (SD 1.5) mL · kg1 · min1
during IPPV and 6.6 (SD 2.2) mL · kg1 ·
min1 during nasal CPAP.
In conclusion, these studies prove that
the Deltatrac II system is a feasible and
reliable device to measure VO2 in venti-
lated infants if air leaks can be excluded.
We determined air leak by measuring
inspiratory and expiratory tidal volume us-
ing the features of the ventilator (Siemens
Servo Ventilator 900 D; Siemens, Erlan-
gen, Germany). As described in the Meth-
ods section, we had to exclude 12 patients
because of air leakage of more than 5%.
TFinally, Berger and Bergstra correctly
pointed out that a shunt ratio can be calcu-
lated using oxygen saturation measurements.
A determination of pulmonary or systemic
blood flow is necessary to calculate abso-
lute shunt volumes.
U. Fakler, MD
J. Hess, MD
German Heart Center
Department of Pediatric Cardiology and
Congenital Heart Disease
Technische Universität München
Munich, Germany
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Triiodothyronine in neonatal heart
surgery: Looking for an answer
To the Editor:
We congratulate Mackie and colleagues1
on their randomized study on triiodothyro-
dine (T3) treatment in neonatal heart sur-
gery. In their study group the authors cor-
rectly enrolled a homogenous group of
infants at highest risk of postoperative low
cardiac output syndrome and marked thy-
roid hormone suppression.2 As already
shown by several other authors, the thyroid
hormone levels are suppressed after cardio-
pulmonary bypass (CPB), decreasing to a
nadir at around 48 hours after CPB and re-
covering over approximately 1 week. Logi-
cally, treatment with T3 after CPB raises the
T3 plasma concentrations to normal levels,
and no negative effects have been demon-
strated so far. Previous studies, as well as
he Journal of Thoracic and Cardiovascularthe study presented, had relatively small
subject numbers, thereby limiting the abil-
ity to determine a clinical effect. This led to
the initiation of the Triiodothyronine for
Infants and Children Undergoing Cardio-
pulmonary Bypass (TRICC) study, a ran-
domized, multicenter clinical trial designed
to determine safety and efficacy of T3 sup-
plementation in children less than 2 years
of age undergoing surgical procedures for
congenital heart disease.3
We would, however, counsel some cau-
tion in the interpretation of the main results
of this study mainly for two reasons:
First, to our knowledge many centers
worldwide would use in these patients peri-
toneal dialysis (PD) in the early postoper-
ative phase to minimize the effects of sys-
temic inflammatory response and achieve
adequate fluid balance.4 Usually peritoneal
catheters are placed at the end of the oper-
ation to drain excess fluid as a routine
institutional procedure, and PD is started
after admission to the intensive care unit
either on a prophylactic basis or after oli-
guria, anuria, fluid overload, hyperkalemia,
or acidosis. PD is able to achieve ade-
quate negative fluid balance in nearly all
instances and treat other underlying
causes simultaneously. Thus the positive
achievement of negative fluid balance at
day 2 versus day 2.5 may be clinically
negligible under most given circum-
stances.
Second, the authors quote the effect of
the T3 infusion on the cardiac output, systolic
blood pressure and, herewith, indirectly on
the requirements of catecholamines. Unfortu-
nately, no information is provided on the
absolute use of vasodilators (such as phe-
noxybenxzamine, sodium nitroprusside, and
milrinone), nor is there differentiation in the
catecholamine use with regard to dopamine.
It is widely known that dopamine has a direct
negative effect on thyroid function and thy-
roid hormone levels in infants and children.5
Other factors such as the use of amiodarone
should be discussed too. Finally, the overall
dropout rate of cardiac output measurements
in both groups (14/42) seems relatively high
and unbalanced between the two small study
groups. This additional information seems
crucial to enable a more objective assessment
of the study.
Despite these limitations, we believe
that the study by Mackie and associates
adds valuable information to the contro-
versial dispute on the efficiency of T3 as
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